Return
Company Page
Angitia Biopharmaceuticals
Founders
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics for serious musculoskeletal diseases. The company is advancing three biologic product candidates in clinical trials for osteoporosis, osteogenesis imperfecta, and spinal fusion, with operations in both the United States and China.
Company Founded in 2018
